Breathe Well Live Well
Condition: Asthma
Interventions: Drug: QMF149; Drug: QMF149; Drug: MF 400; Drug: MF 400; Drug: salmeterol /fluticasone
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Fox 59 |
Indiana makes Asthma and Allergy safety “Honor Roll”
Fox 59 INDIANAPOLIS, IND. (August 11th, 2915) — Millions of kids suffer from asthma or allergies, but a new report out Tuesday says most schools aren't prepared to help them. So, how do schools in our state measure-up? This year, Indiana made “The Honor Roll … Study Shows That First-Trimester Exposure to Asthma Beta-2 Agonist Drugs … New report explores the asthma drugs market in the US 2015-2019 |
View full post on asthma – Google News
Condition: Persistent Asthma
Interventions: Drug: Beclomethasone Dipropionate; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Elevated Blood Eosinophils
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: MK-3641; Biological: Placebo; Drug: Self-injectable epinephrine; Drug: Albuterol/Salbutamol; Drug: Loratadine; Drug: Olopatadine; Drug: Mometasone furoate monohydrate
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting – verified June 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
ProPublica |
Overuse, Safety Questions Cloud Advair's Ascent to Asthma Blockbuster
ProPublica The asthma drug has generated more than $80 billion in global revenues for its maker, GlaxoSmithKline, since its U.S. approval in 2000. With its distinctive purple inhaler, Advair has helped legions of asthma sufferers achieve control of their symptoms. |
View full post on asthma – Google News
Condition: Asthma
Interventions: Biological: Tralokinumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
ProPublica: Safety questions over GSK's Advair linger after years on the …
FiercePharma Recent research suggests that a significant percentage of asthma patients begin using Advair inappropriately, the watchdog says, and that can trigger the "risk of asthma-related death" described on the med's label. And while the FDA in 2010 required … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Placebo; Drug: BI 655066
Sponsor: Boehringer Ingelheim
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Reuters |
GSK, Theravance's Breo Faces Scrutiny Over Safety for Asthma
Bloomberg (Bloomberg) — GlaxoSmithKline Plc and Theravance Inc.'s respiratory drug Breo Ellipta will face questions from a regulatory panel over the safety of expanding its use to treat asthma patients and whether it's suitable for children. Advisers to the U.S … FDA staff finds no new safety problems with Glaxo's asthma drug GSK Studies Found No Asthma Deaths For COPD Drug, FDA Says New Glaxo asthma treatment reviewed by FDA |
View full post on asthma – Google News